LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Clinical and Microbiological effects in High-risk Beef Calves Administered Intranasal or Parenteral Modified-live Virus Vaccines.

Photo from wikipedia

Experimental bovine respiratory syncytial virus (BRSV) infection can enhance Histophilus somni (Hs) disease in calves; we thus hypothesized that modified-live virus (MLV) vaccines containing BRSV may alter Hs carriage. Our… Click to show full abstract

Experimental bovine respiratory syncytial virus (BRSV) infection can enhance Histophilus somni (Hs) disease in calves; we thus hypothesized that modified-live virus (MLV) vaccines containing BRSV may alter Hs carriage. Our objective was to determine effects of an intranasal (IN) trivalent (infectious bovine rhinotracheitis virus [IBRV], parainfluenza-3 virus [PI3V], and BRSV) respiratory vaccine with parenteral (PT) bivalent bovine viral diarrhea virus (BVDV) type I + II vaccine, or a PT pentavalent (BVDV type I and II, IBRV, BRSV, and PI3V) respiratory vaccine, on health, growth, immunity, and nasal pathogen colonization in high-risk beef calves. Calves (n=525) were received in 5 truckload blocks and stratified by body weight (213±18.4 kg), sex, and presence of a pre-existing ear-tag. Pens were spatially arranged in sets of 3 within block and randomly assigned to treatment with an empty pen between treatment groups consisting of: 1) no MLV respiratory vaccination (CON), 2) IN trivalent MLV respiratory vaccine with PT BVDV type I + II vaccine (INT), or 3) PT pentavalent, MLV respiratory vaccine (INJ). Pen was the experimental unit, with 15 pens/treatment and 11 - 12 calves/pen in this 70-d receiving study. Health, performance, and BRSV, Hs, Mycoplasma bovis (Mb), Mannheimia haemolytica (Mh), and Pasteurella multocida (Pm) level in nasal swabs via rtPCR was determined on d 0, 7, 14, and 28, and BRSV-specific serum neutralizing antibody titer, and serum IFN-γ concentration via ELISA, were evaluated on d 0, 14, 28, 42, 56, and 70. Morbidity (P=0.83), mortality (P=0.68) and average daily gain (P≥0.82) did not differ. Serum antibody against BRSV increased with time (P<0.01). There was a treatment × time interaction (P<0.01) for Hs detection; on d 14 and 28, INT (21.1 and 57.1%) were more frequently (P<0.01) Hs positive than CON (3.6 and 25.3%) or INJ (3.4 and 8.4%). Also, INT had reduced (P=0.03) cycle time of Hs positive samples on d 28. No difference (P≥0.17) was found for IFN-γ concentration and Mb, Mh, or Pm detection. The proportion of Mh positive culture from lung specimens differed (P<0.01); INT had fewer (0.0%; 0 of 9) Mh positive lungs than INJ (45.5%; 6 of 13) or CON (74.0%; 14 of 19). Vaccination of high-risk calves with MLV did not clearly impact health or growth during the receiving period. However, INT was associated with altered upper respiratory microbial community in cattle resulting in increased detection and level of Hs.

Keywords: brsv; high risk; vaccine; respiratory; virus

Journal Title: Journal of animal science
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.